| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |